Streetbeat News

AHG

Akso Health Group

https://www.xiaobaimaimai.com

Industry

Financial - Credit Services

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.

Open

1.13

Mkt cap

173M

Volume

15K

High

1.13

P/E Ratio

-4.52

52-wk high

2.90

Low

0.92

Div yield

N/A

52-wk low

0.53

In Monday's intraday session, several healthcare stocks experienced significant movements. Fresh2 Group, Akso Health Group, ChromaDex, Elicio Therapeutics, Immuneering, and Biotricity saw their stock prices increase, with gains ranging from 21.08% to 41.7%. Conversely, Trxade Health, Envoy Medical, CareMax, Titan Pharma, Cargo Therapeutics, and Molecular Templates faced declines, with their stock prices dropping between 17.28% and 33%. CareMax's Q4 earnings were also released.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 5:31 pm

Akso Health Group (AHG) is offering 37.1 million ADS shares at $1.33 each to institutional investors, along with warrants for up to 222.6 million ordinary shares at an exercise price of $0.4933 per share. The offering is part of a Securities Purchase Agreement dated March 5, 2024. The warrants are exercisable immediately and expire in five years. This offering and the warrants are exempt from registration under the Securities Act of 1933. AHG's public float was valued at approximately $276.52 million based on a price per ADS of $2.60 as of February 2, 2024. AHG's ADSs are traded on the Nasdaq under the symbol "AHG", with a closing sale price of $1.23 per ADS on March 5, 2024.

Portfolio Pulse from Benzinga Newsdesk

March 07, 2024 | 5:10 pm

Akso Health Group has filed for a mixed shelf offering with the SEC, allowing it to issue up to $400 million in securities. This strategic move could provide the company with flexible financing options for future growth, acquisitions, or debt management.

Portfolio Pulse from Benzinga Newsdesk

February 26, 2024 | 7:51 pm

In Tuesday's intraday session, several health care stocks showed significant movement. Notably, InVivo Therapeutics (NVIV) surged by 306.0% to $0.9, while BioRestorative Therapies (BRTX) dropped by 57.1% to $1.48. Other gainers include Cyclerion Therapeutics (CYCN), Tenax Therapeutics (TENX), Equillium (EQ), Karyopharm Therapeutics (KPTI), and Immunome (IMNM). Losers also featured Akso Health Group (AHG), Sagimet Biosciences (SGMT), Biolase (BIOL), NanoString Technologies (NSTG), and Apollomics (APLM).

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 5:31 pm

In Friday's intraday session, several healthcare stocks experienced significant movements. Intelligent Bio Solutions (INBS) saw a notable increase of 108.5%, while Atara Biotherapeutics (ATRA) rose by 51.8%. On the downside, Cingulate (CING) dropped by 52.1%, and Biofrontera (BFRI) fell by 35.59%. These movements reflect the volatile nature of healthcare stocks in the market.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 5:31 pm

Meta Platforms, Inc. (META) shares surged over 16% in pre-market trading due to strong fourth-quarter results and a new quarterly dividend. Other stocks also showed significant pre-market movements, with notable gainers including CCSC Technology International Holdings Limited (CCTG) and The Clorox Company (CLX), and losers like AgriFORCE Growing Systems Ltd. (AGRI) and Skechers U.S.A., Inc. (SKX).

Portfolio Pulse from Avi Kapoor

February 02, 2024 | 1:21 pm

In Thursday's intraday session, several healthcare stocks experienced significant movements. NeuroBo Pharmaceuticals (NRBO) led the gainers with a 55.3% increase, while Revelation Biosciences (REVB) saw the largest decrease among the losers, dropping 62.6%. Other notable movers included Kiora Pharmaceuticals (KPRX) and Celularity (CELU) with substantial gains, and InVivo Therapeutics Holdings (NVIV) and Bullfrog AI Holdings (BFRG) with notable losses.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 5:31 pm

In Thursday's pre-market session, several healthcare stocks showed significant movement. Kiora Pharmaceuticals, Salarius Pharmaceuticals, HOOKIPA Pharma, Eterna Therapeutics, Akso Health Group, and OpGen experienced notable gains, with increases ranging from 18.03% to 48.3%. Conversely, Revelation Biosciences, OneMedNet, Bullfrog AI Holdings, Jin Medical International, Trinity Biotech, and 180 Life Sciences saw declines, with decreases ranging from 12.15% to 59.7%. These movements reflect the volatile nature of healthcare stocks in the market.

Portfolio Pulse from Benzinga Insights

February 01, 2024 | 1:06 pm

Akso Health Group (NYSE:AHG) has seen a 15.79% increase in short interest since its last report, with 45 thousand shares sold short, representing 0.22% of its float. The short interest is below the peer group average of 4.95%. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price decline.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 8:45 pm

In Tuesday's pre-market session, health care stocks saw significant movement. MorphoSys, Modular Medical, Akso Health Group, Assure Hldgs, Gain Therapeutics, and Societal CDMO were among the gainers, with increases ranging from 11.49% to 15.1%. Conversely, Allakos, Accelerate Diagnostics, Atreca, Evaxion Biotech, Inventiva, and Akanda were the losers, with declines between 10.64% and 56.5%.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 1:05 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.